New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration
Authors
Keywords
-
Journal
Journal of Ophthalmology
Volume 2012, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2012-02-10
DOI
10.1155/2012/637316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preferred therapies for neovascular age-related macular degeneration
- (2011) Allen Chiang et al. CURRENT OPINION IN OPHTHALMOLOGY
- Ranibizumab treatment administered as needed for occult and minimally classic neovascular membranes in age-related macular degeneration
- (2011) Seungbum Kang et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Bevacizumab versus Ranibizumab for AMD
- (2011) Philip J. Rosenfeld NEW ENGLAND JOURNAL OF MEDICINE
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- EXTEND-I: safety and efficacy of ranibizumab in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
- (2010) Yasuo Tano et al. ACTA OPHTHALMOLOGICA
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2
- (2010) Prema Abraham et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular DegenerationClinical and Economic Impact
- (2010) Omesh P. Gupta et al. OPHTHALMOLOGY
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- ANATOMICAL BENEFIT FROM RANIBIZUMAB TREATMENT OF PREDOMINANTLY CLASSIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN THE 2-YEAR ANCHOR STUDY
- (2010) Srinivas R Sadda et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Effects of Ranibizumab in Patients with Subfoveal Choroidal Neovascularization Attributable to Age-related Macular Degeneration
- (2009) Simon P. Rothenbuehler et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Current and future therapies for age-related macular degeneration
- (2009) Julia Beutel et al. EXPERT OPINION ON EMERGING DRUGS
- VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration
- (2009) James A Dixon et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups
- (2009) Seungbum Kang et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration
- (2009) David S. Boyer et al. OPHTHALMOLOGY
- Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration
- (2009) Hajir Dadgostar et al. OPHTHALMOLOGY
- A prospective study on intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration of different durations
- (2008) Peep V. Algvere et al. ACTA OPHTHALMOLOGICA
- Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties
- (2008) Alan F. Cruess et al. ACTA OPHTHALMOLOGICA
- Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-related Macular Degeneration (FOCUS): Year 2 Results
- (2008) Andrew N. Antoszyk et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- Aflibercept
- (2008) &NA; Drugs in research & development
- Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: A One-year Prospective Study
- (2007) Ziad F. Bashshur et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started